![Magnus Tolleshaug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 170 543 $ al 31/05/2026
Magnus Tolleshaug currently works at Vistin Pharma ASA, as Chief Executive Officer from 2024.
Mr. Tolleshaug also formerly worked at Takeda A, as Head-Global Launch Excellence.
Mr. Tolleshaug received his graduate degree from Norwegian University of Science & Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VISTIN PHARMA ASA 0,17 % | 31/12/2024 | 75.000 ( 0,17 % ) | 170 543 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VISTIN PHARMA ASA | Director Ejecutivo | 01/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Norwegian University of Science & Technology
 Norwegian University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vistin Pharma ASA
 Vistin Pharma ASA Pharmaceuticals: MajorHealth Technology engages in the production of active pharmaceutical ingredients for metformin and opiates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
